Kancera AB (KANC)

Currency in SEK
1.560
+0.004(+0.26%)
Closed·
KANC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
KANC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5261.612
52 wk Range
0.8002.980
Key Statistics
Prev. Close
1.556
Open
1.612
Day's Range
1.526-1.612
52 wk Range
0.8-2.98
Volume
146.62K
Average Volume (3m)
378.6K
1-Year Change
-9.72%
Book Value / Share
0.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KANC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Kancera AB Company Profile

Kancera AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops KAN571, a ROR1 inhibitor for the treatment of mantle cell lymphoma and B-cell malignancy. Kancera AB (publ) was incorporated in 2010 and is headquartered in Solna, Sweden.

Compare KANC to Peers and Sector

Metrics to compare
KANC
Peers
Sector
Relationship
P/E Ratio
−4.2x−3.2x−0.5x
PEG Ratio
−0.09−0.050.00
Price/Book
3.8x4.1x2.6x
Price / LTM Sales
-15.5x3.2x
Upside (Analyst Target)
9.0%9.2%41.7%
Fair Value Upside
Unlock1.6%6.1%Unlock

Earnings

Latest Release
May 23, 2025
EPS / Forecast
-0.11 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

KANC Income Statement

FAQ

What Stock Exchange Does Kancera AB Trade On?

Kancera AB is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Kancera AB?

The stock symbol for Kancera AB is "KANC."

What Is the Kancera AB Market Cap?

As of today, Kancera AB market cap is 189.05M.

What Is Kancera AB's Earnings Per Share (TTM)?

The Kancera AB EPS (TTM) is -0.37.

When Is the Next Kancera AB Earnings Date?

Kancera AB will release its next earnings report on 21 Aug 2025.

From a Technical Analysis Perspective, Is KANC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kancera AB Stock Split?

Kancera AB has split 9 times.

How Many Employees Does Kancera AB Have?

Kancera AB has 5 employees.

What is the current trading status of Kancera AB (KANC)?

As of 26 Jul 2025, Kancera AB (KANC) is trading at a price of 1.56, with a previous close of 1.56. The stock has fluctuated within a day range of 1.53 to 1.61, while its 52-week range spans from 0.80 to 2.98.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.